Report

  • Home |
  • Reports |
  • Global Rabies Vaccine Market by Product Type (Vero Cell Rabies Vaccine, BHK, Chi....
src

Global Rabies Vaccine Market by Product Type (Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Other) and by End-Users/Application (Pre-exposure Prophylaxis, Post-exposure Prophylaxis) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

The report on the global Rabies Vaccine market analyzes complete scenario i.e., existing as well as future visions of Rabies Vaccine market. It includes detailed overview of Rabies Vaccine market along with market pictures. Additionally, report has included complete data of the various segments in the global Rabies Vaccine market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global Rabies Vaccine market report offers in-depth insights, revenue details, and other vital information regarding the global Rabies Vaccine market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2026. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of Rabies Vaccine market.

Market Segmentation:
Segmentation by Type Vero Cell Rabies Vaccine 
BHK 
Chick Embryo Cell Rabies Vaccine  
Other
Segmentation by Application Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, Rabies Vaccine market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global Rabies Vaccine market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Rabies Vaccine Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each Rabies Vaccine market player.
  • Region-wise and country-wise breakdown of the Rabies Vaccine market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global Rabies Vaccine market.
  • Year-on-year growth of the global Rabies Vaccine market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish Rabies Vaccine market and nurture business as it explains current global market as well as future market.
Table of Content

Chapter 1 Rabies Vaccine Market Overview 18
1.1 Product Overview and Scope of Rabies Vaccine 18
1.2 Rabies Vaccine Segment by Types (Product Category) 20
            1.2.1 Global Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Comparison by Types (2014-2019) 20
            1.2.2 Global Rabies Vaccine Revenue Market Share (%) by Types in 2018 21
            1.2.3 Vero Cell Rabies Vaccine 22
            1.2.4 BHK 23
            1.2.5 Chick Embryo Cell Rabies Vaccine 24
            1.2.6 Other 25
1.3 Global Rabies Vaccine Segment by Applications 26
            1.3.1 Global Rabies Vaccine Revenue (USD Million) Comparison by Applications (2014-2026) 26
            1.3.2 Pre-exposure Prophylaxis 28
            1.3.3 Post-exposure Prophylaxis 29
1.4 Global Rabies Vaccine Market by Regions (2014-2026) 30
            1.4.1 Global Rabies Vaccine Market Size and Growth Rate (%) Comparison by Regions (2014-2026) 30
            1.4.2 North America Rabies Vaccine Status and Prospect (2014-2026) 32
            1.4.3 Europe Rabies Vaccine Status and Prospect (2014-2026) 33
            1.4.4 China Rabies Vaccine Status and Prospect (2014-2026) 34
            1.4.5 Japan Rabies Vaccine Status and Prospect (2014-2026) 35
            1.4.6 Southeast Asia Rabies Vaccine Status and Prospect (2014-2026) 36
            1.4.7 India Rabies Vaccine Status and Prospect (2014-2026) 37
            1.4.8 South America Rabies Vaccine Status and Prospect (2014-2026) 38
            1.4.9 Middle East & Africa Rabies Vaccine Status and Prospect (2014-2026) 39
1.5 Global Rabies Vaccine Market Size (2014-2026) 40
            1.5.1 Global Rabies Vaccine Revenue Status and Outlook (2014-2026) 40
            
Chapter 2 Global Rabies Vaccine Market Competition by Manufacturers 41
2.1 Global Rabies Vaccine Revenue and Share by Manufacturers (2013-2017) 41

Chapter 3 Company (Top Players) Profiles and Key Data 44
3.1 GlaxoSmithKline plc 44
            3.1.1 GlaxoSmithKline plc Company Basic Information, Manufacturing Base, Sales Area and its Competitors 44
            3.1.2 Business Segment/ Overview 45
            3.1.3 Rabies Vaccine Types Specification 46
            3.1.4 Key Developments 48
            3.1.5 Business Strategy 49
3.2 Sanofi Pasteur 50
            3.2.1 Sanofi Pasteur Company Basic Information, Manufacturing Base, Sales Area and its Competitors 50
            3.2.2 Business Segment/ Overview 51
            3.2.3 Rabies Vaccine Types Specification 52
            3.2.4 Business Strategy 54
3.3 Liaoning Chengda Biotechnology CO. LTD. 55
            3.3.1 Liaoning Chengda Biotechnology CO. LTD. Company Basic Information, Manufacturing Base, Sales Area and its Competitors 55
            3.3.2 Business Segment/ Overview 56
            3.3.3 Rabies Vaccine Types Specification 57
            3.3.4 Business Strategy 59
3.4 Yisheng Biopharma CO., Ltd. 60
            3.4.1 Yisheng Biopharma CO., Ltd. Company Basic Information, Manufacturing Base, Sales Area and its Competitors 60
            3.4.2 Business Segment/ Overview 61
            3.4.3 Key Developments 64
            3.4.4 Business Strategy 65
3.5 Changchun BCHT Biotechnology Co. Ltd. 66
            3.5.1 Changchun BCHT Biotechnology Co. Ltd. Company Basic Information, Manufacturing Base, Sales Area and its Competitors 66
            3.5.2 Business Segment/ Overview 67
            3.5.3 Rabies Vaccine Types Specification 68
            3.5.4 Business Strategy 70
3.6 Dalian Hissen BioPharm Co., Ltd. 71
            3.6.1 Dalian Hissen BioPharm Co., Ltd. Company Basic Information, Manufacturing Base, Sales Area and its Competitors 71
            3.6.2 Business Segment/ Overview 72
            3.6.3 Rabies Vaccine Types Specification 73
            3.6.4 Business Strategy 75
3.7 Serum Institute of India Private Limited 76
            3.7.1 Serum Institute of India Private Limited Company Basic Information, Manufacturing Base, Sales Area and its Competitors 76
            3.7.2 Business Segment/ Overview 77
            3.7.3 Rabies Vaccine Types Specification 78
            3.7.4 Business Strategy 79
            
Chapter 4 Global Rabies Vaccine Revenue by Regions (2014-2019) 80
4.1 Global Rabies Vaccine Revenue and Market Share (%) by Regions (2014-2019) 80

Chapter 5 Global Rabies Vaccine Revenue by Types 84
5.1 Global Rabies Vaccine Revenue and Market Share (%) by Types (2014-2019) 84

Chapter 6 Global Rabies Vaccine Market Analysis by Applications 87
6.1 Global Rabies Vaccine Revenue (USD Million) and Market Share (%) by Applications (2014-2019) 87
6.2 Global Rabies Vaccine Revenue Growth Rate by Applications (2014-2019) 91

Chapter 7 North America Rabies Vaccine Market Development Status and Outlook 92
7.1 North America Rabies Vaccine Market Size (2014-2019) 92
            7.1.1 North America Rabies Vaccine Market Size by Type (2014-2019) 93
7.2 North America Rabies Vaccine Market Size (2014-2019) 94
            7.2.1 North America Rabies Vaccine Market Size by Application (2014-2019) 95
            
Chapter 8 Europe Rabies Vaccine Market Development Status and Outlook 96
8.1 Europe Rabies Vaccine Market Size (2014-2019) 96
            8.1.1 Europe Rabies Vaccine Market Size by Type (2014-2019) 97
8.2 Europe Rabies Vaccine Market Size (2014-2019) 98
            8.2.1 Europe Rabies Vaccine Market Size by Application (2014-2019) 99
            
Chapter 9 China Rabies Vaccine Market Development Status and Outlook 100
9.1 China Rabies Vaccine Market Size (2014-2019) 100
            9.1.1 China Rabies Vaccine Market Size by Type (2014-2019) 101
9.2 China Rabies Vaccine Market Size (2014-2019) 102
            9.2.1 China Rabies Vaccine Market Size by Application (2014-2019) 103
            
Chapter 10 Japan Rabies Vaccine Market Development Status and Outlook 104
10.1 Japan Rabies Vaccine Market Size (2014-2019) 104
            10.1.1 Japan Rabies Vaccine Market Size by Type (2014-2019) 105
10.2 Japan Rabies Vaccine Market Size (2014-2019) 107
            10.2.1 Japan Rabies Vaccine Market Size by Application (2014-2019) 108
            10.2.2 Japan Rabies Vaccine Market Size by Application (2014-2019) 109
            
Chapter 11 Southeast Asia Rabies Vaccine Market Development Status and Outlook 110
11.1 Southeast Asia Rabies Vaccine Market Size (2014-2019) 110
            11.1.1 Southeast Asia Rabies Vaccine Market Size by Type (2014-2019) 111
11.2 Southeast Asia Rabies Vaccine Market Size (2014-2019) 113
            11.2.1 Southeast Asia Rabies Vaccine Market Size by Application (2014-2019) 114
            
Chapter 12 India Rabies Vaccine Market Development Status and Outlook 115
12.1 India Rabies Vaccine Market Size (2014-2019) 115
            12.1.1 India Rabies Vaccine Market Size by Type (2014-2019) 116
12.2 India Rabies Vaccine Market Size (2014-2019) 118
            12.2.1 India Rabies Vaccine Market Size by Application (2014-2019) 119
            
Chapter 13 South America Rabies Vaccine Market Development Status and Outlook 120
13.1 South America Rabies Vaccine Market Size (2014-2019) 120
            13.1.1 South America Rabies Vaccine Market Size by Type (2014-2019) 121
13.2 South America Rabies Vaccine Market Size (2014-2019) 122
            13.2.1 South America Rabies Vaccine Market Size by Application (2014-2019) 123
            
Chapter 14 Middle East & Africa Rabies Vaccine Market Development Status and Outlook 124
14.1 Middle East & Africa Rabies Vaccine Market Size (2014-2019) 124
            14.1.1 Middle East & Africa Rabies Vaccine Market Size by Type (2014-2019) 125
14.2 Middle East & Africa Rabies Vaccine Market Size (2014-2019) 126
            14.2.1 Middle East & Africa Rabies Vaccine Market Size by Application (2014-2019) 127
            
Chapter 15 Rabies Vaccine Manufacturing Cost Analysis 128
15.1 Proportion of Manufacturing Cost Structure 128
            15.1.1 Raw Materials 128
            15.1.2 Labor Cost 129
            15.1.3 USA Labor Cost Analysis 129
            15.1.4 EU Labor Costs Analysis 131
            15.1.5 China Labor Costs Analysis 132
            15.1.6 Manufacturing Expenses 134
            
Chapter 16 Marketing Strategy Analysis, Distributors/Traders 135
16.1 Marketing Channel 135
            16.1.1 Direct Marketing 136
            16.1.2 Indirect Marketing 136
            16.1.3 Marketing Channel Development Trend 137
16.2 Market Positioning 137
            16.2.1 Pricing Strategy 138
            
Chapter 17 Global Rabies Vaccine Market Forecast (2019-2026) 139
17.1 Global Rabies Vaccine Revenue Forecast (2019-2026) 139
            17.1.1 Global Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 139
17.2 Global Rabies Vaccine Revenue (USD Million) Forecast by Regions (2019-2026) 140
            17.2.1 North America Rabies Vaccine Revenue (USD Million) Forecast (2019-2026) 142
            17.2.2 Europe Rabies Vaccine Revenue (USD Million) Forecast (2019-2026) 143
            17.2.3 China Rabies Vaccine and Revenue (USD Million) Forecast (2019-2026) 144
            17.2.4 Japan Rabies Vaccine and Revenue (USD Million) Forecast (2019-2026) 145
            17.2.5 Southeast Asia Rabies Vaccine and Revenue (USD Million) Forecast (2019-2026) 146
            17.2.6 India Rabies Vaccine and Revenue (USD Million) Forecast (2019-2026) 147
            17.2.7 South America Rabies Vaccine and Revenue (USD Million) Forecast (2019-2026) 148
            17.2.8 Middle East & Africa Rabies Vaccine and Revenue (USD Million) Forecast (2019-2026) 149
17.3 Global Rabies Vaccine Revenue Forecast by Type (2019-2026) 150
17.4 Global Rabies Vaccine Revenue (USD Million) Forecast by Application (2019-2026) 152

Chapter 18 North America Rabies Vaccine Market Development Status and Outlook 154
18.1 North America Rabies Vaccine Market Size (2019-2026) 154
            18.1.1 North America Rabies Vaccine Market Size by Type (2019-2026) 155
18.2 North America Rabies Vaccine Market Size (2019-2026) 156
            18.2.1 North America Rabies Vaccine Market Size by Application (2019-2026) 157
            
Chapter 19 Europe Rabies Vaccine Market Development Status and Outlook 158
19.1 Europe Rabies Vaccine Market Size (2019-2026) 158
            19.1.1 Europe Rabies Vaccine Market Size by Type (2019-2026) 159
19.2 Europe Rabies Vaccine Market Size (2019-2026) 160
            19.2.1 Europe Rabies Vaccine Market Size by Application (2019-2026) 161
            
Chapter 20 China Rabies Vaccine Market Development Status and Outlook 162
20.1 China Rabies Vaccine Market Size (2019-2026) 162
            20.1.1 China Rabies Vaccine Market Size by Type (2019-2026) 163
20.2 China Rabies Vaccine Market Size (2019-2026) 164
            20.2.1 China Rabies Vaccine Market Size by Application (2019-2026) 165
            
Chapter 21 Japan Rabies Vaccine Market Development Status and Outlook 166
21.1 Japan Rabies Vaccine Market Size (2019-2026) 166
            21.1.1 Japan Rabies Vaccine Market Size by Type (2019-2026) 167
21.2 Japan Rabies Vaccine Market Size (2019-2026) 168
            21.2.1 Japan Rabies Vaccine Market Size by Application (2019-2026) 169
            
Chapter 22 Southeast Asia Rabies Vaccine Market Development Status and Outlook 170
22.1 Southeast Asia Rabies Vaccine Market Size (2019-2026) 170
            22.1.1 Southeast Asia Rabies Vaccine Market Size by Type (2019-2026) 171
22.2 Southeast Asia Rabies Vaccine Market Size (2019-2026) 172
            22.2.1 Southeast Asia Rabies Vaccine Market Size by Application (2019-2026) 173
            
Chapter 23 India Rabies Vaccine Market Development Status and Outlook 174
23.1 India Rabies Vaccine Market Size (2019-2026) 174
            23.1.1 India Rabies Vaccine Market Size by Type (2019-2026) 175
23.2 India Rabies Vaccine Market Size (2019-2026) 176
            23.2.1 India Rabies Vaccine Market Size by Application (2019-2026) 177
            
Chapter 24 South America Rabies Vaccine Market Development Status and Outlook 178
24.1 South America Rabies Vaccine Market Size (2019-2026) 178
            24.1.1 South America Rabies Vaccine Market Size by Type (2019-2026) 179
24.2 South America Rabies Vaccine Market Size (2019-2026) 180
            24.2.1 South America Rabies Vaccine Market Size by Application (2019-2026) 181
            
Chapter 25 Middle East & Africa Rabies Vaccine Market Development Status and Outlook 182
25.1 Middle East & Africa Rabies Vaccine Market Size (2019-2026) 182
            25.1.1 Middle East & Africa Rabies Vaccine Market Size by Type (2019-2026) 183
25.2 Middle East & Africa Rabies Vaccine Market Size (2019-2026) 184
            25.2.1 Middle East & Africa Rabies Vaccine Market Size by Application (2019-2026) 185
            
Chapter 26 Research Findings and Conclusion 186

List of Figures 

FIG. 1 Product Picture of Rabies Vaccine 19
FIG. 2 Global Rabies Vaccine Revenue Market Share (%) by Types in 2018 21
FIG. 3 Global Vero Cell Rabies Vaccine Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026) 22
FIG. 4 BHK Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026) 23
FIG. 5 Global Chick Embryo Cell Rabies Vaccine Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026) 24
FIG. 6 Global Other Market Revenue (USD Million) and Growth Rate (%), (2014 – 2026) 25
FIG. 7 Global Rabies Vaccine Revenue (USD Million) Market Share (%) by Applications in 2018 27
FIG. 8 Global Rabies Vaccine Market for Pre-exposure Prophylaxis Consumption and Growth Rate (%), (2014 – 2026) 28
FIG. 9 Global Rabies Vaccine Market for Post-exposure Prophylaxis Consumption and Growth Rate (%), (2014 to 2026) 29
FIG. 10 Global Rabies Vaccine Market Size Comparison and Growth Rate (%) by Regions (2014-2026) 30
FIG. 11 North America Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 32
FIG. 12 Europe Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 33
FIG. 13 China Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 34
FIG. 14 Japan Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 35
FIG. 15 Southeast Asia Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 36
FIG. 16 India Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 37
FIG. 17 South America Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 38
FIG. 18 Middle East & Africa Rabies Vaccine Revenue (USD Million) and Growth Rate (2014-2026) 39
FIG. 19 Global Rabies Vaccine Revenue (USD Million) Status and Outlook (2014-2026) 40
FIG. 20 2018 Global Rabies Vaccine Revenue Share by Manufacturers 43
FIG. 21 GlaxoSmithKline plc Revenue Market Share (%) (2014-2018) 47
FIG. 22 Sanofi Pasteur Revenue Market Share (%) (2014-2018) 53
FIG. 23 Liaoning Chengda Biotechnology CO. LTD. Revenue Market Share (%) (2014-2018) 58
FIG. 24 Yisheng Biopharma CO., Ltd. Revenue Market Share (%) (2014-2018) 63
FIG. 25 Changchun BCHT Biotechnology Co. Ltd. Revenue Market Share (%) (2014-2018) 69
FIG. 26 Dalian Hissen BioPharm Co., Ltd. Revenue Market Share (%) (2014-2018) 74
FIG. 27 Global Rabies Vaccine Revenue Market Share (%) by Regions (2014-2019) 82
FIG. 28 Global Rabies Vaccine Revenue Market Share (%) by Regions, 2018 83
FIG. 29 Revenue Share of Rabies Vaccine by Types (2014-2019) 85
FIG. 30 2018 Revenue Market Share (%) of Rabies Vaccine by Types 86
FIG. 31 Global Rabies Vaccine Consumption Market Share (%) by Applications (2014-2019) 89
FIG. 32 Global Rabies Vaccine Consumption Market Share (%) by Applications in 2018 90
FIG. 33 North America Rabies Vaccine Revenue Market Share (%) by Type (2014-2019) 92
FIG. 34 North America Rabies Vaccine Market Size by Type 2018 93
FIG. 35 North America Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 94
FIG. 36 North America Rabies Vaccine Market Size by Application 2018 95
FIG. 37 Europe Rabies Vaccine Revenue Market Share (%) by Type (2014-2019) 96
FIG. 38 Europe Rabies Vaccine Market Size by Type 2018 97
FIG. 39 Europe Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 98
FIG. 40 Europe Rabies Vaccine Market Size by Application 2018 99
FIG. 41 China Rabies Vaccine Revenue Market Share (%) by Type (2014-2019) 100
FIG. 42 China Rabies Vaccine Market Size by Type 2018 101
FIG. 43 China Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 102
FIG. 44 China  Rabies Vaccine Market Size by Application 2018 103
FIG. 45 Japan Rabies Vaccine Revenue Market Share (%) by Types (2014-2019) 104
FIG. 46 Japan Rabies Vaccine Market Size by Type 2018 106
FIG. 47 Japan Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 107
FIG. 48 Japan Rabies Vaccine Market Size by Application 2018 109
FIG. 49 Southeast Asia Rabies Vaccine Revenue Market Share (%) by Type (2014-2019) 110
FIG. 50 Southeast Asia Rabies Vaccine Market Size by Type 2018 112
FIG. 51 Southeast Asia Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 113
FIG. 52 Southeast Asia Rabies Vaccine Market Size by Application 2018 114
FIG. 53 India Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 115
FIG. 54 India Rabies Vaccine Market Size by Type 2018 117
FIG. 55 India Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 118
FIG. 56 India Rabies Vaccine Market Size by Application 2018 119
FIG. 57 South America Rabies Vaccine Revenue Market Share (%) by Type (2014-2019) 120
FIG. 58 South America Rabies Vaccine Market Size by Type 2018 121
FIG. 59 South America Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 122
FIG. 60 South America Rabies Vaccine Market Size by Application 2018 123
FIG. 61 Middle East & Africa Rabies Vaccine Revenue Market Share (%) by Type (2014-2019) 124
FIG. 62 Middle East & Africa Rabies Vaccine Market Size by Type 2018 125
FIG. 63 Middle East & Africa Rabies Vaccine Revenue Market Share (%) by Application (2014-2019) 126
FIG. 64 Middle East & Africa Rabies Vaccine Market Size by Application 2018 127
FIG. 65 Manufacturing Cost Structure of Rabies Vaccine 128
FIG. 66 USA Labor Cost Analysis 129
FIG. 67 Cost of Employing a Factory Worker 130
FIG. 68 2017 Estimated Labor Costs for the Whole Economy in EUR 131
FIG. 69 Monthly Minimum Wages in Asia 2016 132
FIG. 70 China Labor Costs 133
FIG. 71 Rabies Vaccine Marketing Channels Status 135
FIG. 72 Global Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 139
FIG. 73 Global Rabies Vaccine Revenue Market Share (%) Forecast by Regions (2019-2026) 141
FIG. 74 North America Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 142
FIG. 75 Europe Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 143
FIG. 76 China Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 144
FIG. 77 Japan Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 145
FIG. 78 Southeast Asia Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 146
FIG. 79 India Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 147
FIG. 80 South America Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 148
FIG. 81 Middle East & Africa Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Forecast (2019-2026) 149
FIG. 82 Global Rabies Vaccine Revenue Market Share (%) Forecast by Type (2019-2026) 151
FIG. 83 Global Rabies Vaccine Consumption Forecast by Application (2019-2026) 153
FIG. 84 North America Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 154
FIG. 85 North America Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 156
FIG. 86 Europe Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 158
FIG. 87 Europe Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 160
FIG. 88 China Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 162
FIG. 89 China Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 164
FIG. 90 Japan Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 166
FIG. 91 Japan Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 168
FIG. 92 Southeast Asia Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 170
FIG. 93 Southeast Asia Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 172
FIG. 94 India Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 174
FIG. 95 India Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 176
FIG. 96 South America Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 178
FIG. 97 South America Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 180
FIG. 98 Middle East & Africa Rabies Vaccine Revenue Market Share (%) by Type (2019-2026) 182
FIG. 99 Middle East & Africa Rabies Vaccine Revenue Market Share (%) by Application (2019-2026) 184

List of Tables

TABLE 1 Global Rabies Vaccine Revenue (USD Million) and Growth Rate (%) Comparison by Types (2014-2019) 20
TABLE 2 Global Rabies Vaccine Revenue (USD Million) Comparison by Applications (2014-2026) 26
TABLE 3 Rabies Vaccine Market Revenue (USD Million) Comparison by Regions (2014-2026) 31
TABLE 4 Global Rabies Vaccine Revenue (USD Million) by Manufacturers (2014-2018) 41
TABLE 5 Global Rabies Vaccine Revenue Share by Manufacturers (2014-2018) 42
TABLE 6 Global Rabies Vaccine Revenue Share by Manufacturers (2014-2018) 43
TABLE 7 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors 44
TABLE 8 GlaxoSmithKline plc Revenue (USD Billion), Gross Margin (%) and Market Share (%) (2014-2018) 46
TABLE 9 Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors 50
TABLE 10 Sanofi Pasteur Revenue (USD Billion), Gross Margin (%) and Market Share (%) (2014-2018) 52
TABLE 11 Liaoning Chengda Biotechnology CO. LTD. Basic Information, Manufacturing Base, Sales Area and Its Competitors 55
TABLE 12 Liaoning Chengda Biotechnology CO. LTD. Revenue (USD Billion), Gross Margin (%) and Market Share (%) (2014-2018) 57
TABLE 13 Yisheng Biopharma CO., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors 60
TABLE 14 Yisheng Biopharma CO., Ltd. Revenue (USD Billion), Gross Margin (%) and Market Share (%) (2014-2018) 62
TABLE 15 Changchun BCHT Biotechnology Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors 66
TABLE 16 Changchun BCHT Biotechnology Co. Ltd. Revenue (USD Billion), Gross Margin (%) and Market Share (%) (2014-2018) 68
TABLE 17 Dalian Hissen BioPharm Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors 71
TABLE 18 Dalian Hissen BioPharm Co., Ltd. Revenue (USD Billion), Gross Margin (%) and Market Share (%) (2014-2018) 73
TABLE 19 Serum Institute of India Private Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors 76
TABLE 20 Global Rabies Vaccine Revenue (USD Million) by Regions (2014-2019) 80
TABLE 21 Global Rabies Vaccine Revenue Market Share (%) by Regions (2014-2019) 81
TABLE 22 Global Rabies Vaccine Revenue (USD Million) by Types (2014-2019) 84
TABLE 23 Global Rabies Vaccine Revenue Share (%) by Types (2014-2019) 84
TABLE 24 Global Rabies Vaccine Revenue (USD Million) by Applications (2014-2019) 87
TABLE 25 Global Rabies Vaccine Consumption Market Share (%) by Applications (2014-2019) 88
TABLE 26 Global Rabies Vaccine Revenue Growth Rate by Applications (2014-2019) 91
TABLE 27 North America Rabies Vaccine Market Size by Type (2014-2019) 93
TABLE 28 North America Rabies Vaccine Market Size by Application (2014-2019) 95
TABLE 29 Europe Rabies Vaccine Market Size by Type (2014-2019) 97
TABLE 30 Europe Rabies Vaccine Market Size by Application (2014-2019) 99
TABLE 31 China Rabies Vaccine Market Size by Type (2014-2019) 101
TABLE 32 China Rabies Vaccine Market Size by Application (2014-2019) 103
TABLE 33 Japan Rabies Vaccine Market Size by Type (2014-2019) 105
TABLE 34 Japan Rabies Vaccine Market Size by Application (2014-2019) 108
TABLE 35 Southeast Asia Rabies Vaccine Market Size by Type (2014-2019) 111
TABLE 36 Southeast Asia Rabies Vaccine Market Size by Application (2014-2019) 114
TABLE 37 India Rabies Vaccine Market Size by Type (2014-2019) 116
TABLE 38 India Rabies Vaccine Market Size by Application (2014-2019) 119
TABLE 39 South America Rabies Vaccine Market Size by Type (2014-2019) 121
TABLE 40 South America Rabies Vaccine Market Size by Application (2014-2019) 123
TABLE 41 Middle East & Africa Rabies Vaccine Market Size by Type (2014-2019) 125
TABLE 42 Middle East & Africa Rabies Vaccine Market Size by Application (2014-2019) 127
TABLE 43 Global Rabies Vaccine Revenue (USD Million) Forecast by Regions (2019-2026) 140
TABLE 44 Global Rabies Vaccine Revenue (USD Million) Forecast by Type (2019-2026) 150
TABLE 45 Global Rabies Vaccine Revenue (USD Million) Forecast by Application (2019-2026) 152
TABLE 46 North America Rabies Vaccine Market Size by Type (2019-2026) 155
TABLE 47 North America Rabies Vaccine Market Size by Application (2019-2026) 157
TABLE 48 Europe Rabies Vaccine Market Size by Type (2019-2026) 159
TABLE 49 Europe Rabies Vaccine Market Size by Application (2019-2026) 161
TABLE 50 China Rabies Vaccine Market Size by Type (2019-2026) 163
TABLE 51 China Rabies Vaccine Market Size by Application (2019-2026) 165
TABLE 52 Japan Rabies Vaccine Market Size by Type (2019-2026) 167
TABLE 53 Japan Rabies Vaccine Market Size by Application (2019-2026) 169
TABLE 54 Southeast Asia Rabies Vaccine Market Size by Type (2014-2019) 171
TABLE 55 Southeast Asia Rabies Vaccine Market Size by Application (2019-2026) 173
TABLE 56 India Rabies Vaccine Market Size by Type (2019-2026) 175
TABLE 57 India Rabies Vaccine Market Size by Application (2019-2026) 177
TABLE 58 South America Rabies Vaccine Market Size by Type (2019-2026) 179
TABLE 59 South America Rabies Vaccine Market Size by Application (2019-2026) 181
TABLE 60 Middle East & Africa Rabies Vaccine Market Size by Type (2019-2026) 183
TABLE 61 Middle East & Africa Rabies Vaccine Market Size by Application (2019-2026) 185


 
No Methodology
Global Rabies Vaccine Market Trends:
The global Rabies Vaccine is estimated to be worth USD 8,448.75 million in 2019 and is projected to reach USD 12,124.39 million by 2026, at a CAGR of 5.30% from 2019 to 2026. Rabies vaccine used to prevent the rabies. It is used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite. After exposure vaccination is typically used along with rabies immunoglobulin. This rabies vaccine is safe for all age groups. Vaccines are effective for humans and other animals. Vaccinating dogs is very effective in preventing the spread of rabies to humans.

Increase in incidences of animal bites such as dog bites drive the market. And rabies vaccination side effects such as high fever, weakness, toes, swallowing, unbalance and eye movement problem creates negative impact on global rabies vaccine market growth. All these factors create the some positive as well as negative impact on the global rabies vaccine market.

Global Rabies Vaccine Market, By Type:
Global rabies vaccine market is divided into various types such as Vero cell rabies vaccine, BHK, chick embryo cell rabies vaccine, and other. On the basis of type, Vero Cell Rabies Vaccine accounted for largest share of total revenue generated. Because, this type of vaccine is easily available in the market as compared to other types. So, people prefer this.
 
Global Rabies Vaccine, By Application:
Pre-exposure Prophylaxis and Post-Exposure Prophylaxis are the two types of applications for the global rabies vaccine market. The demand of Global Rabies Vaccine Market is highest from Post-Exposure Prophylaxis.

Global Rabies Vaccine market, By Region:
Report covers the region wise analysis, global Rabies Vaccine can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, aaa leads the global Rabies Vaccine share due to ….. aaa region is followed by aaa and aaa.
 
Major Market Players:
The research study includes profiles of leading companies operating in the global Rabies Vaccine market. Key players profiled in the report include: GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, BCHT, Hissen, and Others.

Global Rabies Vaccine Market Report Scope:
Report Parameters Details of Parameter
Market Size 2014-2026
Based Year 2018
Forecast Period Covered 2019-2026
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Other
Applications Pre-exposure Prophylaxis, Post-exposure Prophylaxis
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, BCHT, Hissen, and Others

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global Rabies Vaccine market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Rabies Vaccine Market: Product analysis
  • Vero Cell Rabies Vaccine
  • BHK
  • Chick Embryo Cell Rabies Vaccine
  • Other
Global Rabies Vaccine Market: Application analysis
  • Pre-exposure Prophylaxis
  • Post-exposure Prophylaxis
Market, By regions:
In addition, Rabies Vaccine report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)